Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 259-160-7 | CAS number: 54423-67-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 14.7 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 18
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 264 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response forhuman health, Modification of the starting point, Figure R.8-3, page 27.
- Justification:
- Dose starting point is a NOAEL.
- AF for differences in duration of exposure:
- 2
- Justification:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Table R. 8-5, page 35.
- AF for intraspecies differences:
- 3
- Justification:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Appendix R.8-3, Table R.8-19, page77.
- AF for the quality of the whole database:
- 3
- Justification:
- Due to lack of reproductive study data.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 240 mg/m³
- Most sensitive endpoint:
- acute toxicity
DNEL related information
- Overall assessment factor (AF):
- 3
- Modified dose descriptor starting point:
- NOAEC
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 240 mg/m³
- Most sensitive endpoint:
- acute toxicity
DNEL related information
- Overall assessment factor (AF):
- 3
- Dose descriptor starting point:
- NOAEC
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 4.2 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 72
- Modified dose descriptor starting point:
- NOAEL
- Explanation for the modification of the dose descriptor starting point:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Section R.8.4.3.1. pages 30-32, Tables R.8-3 & R.8-4.
- Justification:
- Not applicable, starting concentration is a NOAEL.
- AF for differences in duration of exposure:
- 2
- Justification:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Table R.8-5, page 35
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Table R.8-3 for the rat.
- Justification:
- .Allometric scalling was employeed.
- AF for intraspecies differences:
- 3
- Justification:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Appendix R.8-3, Table R.8-19, page 77.
- AF for the quality of the whole database:
- 3
- Justification:
- Due to lack of reproductive study data.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 4.2 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 72
- DNEL extrapolated from long term DNEL
- Modified dose descriptor starting point:
- NOAEL
- Explanation for the modification of the dose descriptor starting point:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Section R.8.4.3.1. pages 30-32, Tables R.8-
- Justification:
- Not applicable, starting concentration is a NOAEL.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Table R.8-3 for the rat.
- AF for other interspecies differences:
- 3
- Justification:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Appendix R.8-3, Table R.8-19, page 77.
- Justification:
- Allometric scalling was employeed.
- AF for the quality of the whole database:
- 3
- Justification:
- Due to lack of reproductive study data.
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - workers
The rat GLP, O.E.C.D. Testing Guideline 408 oral 90-Day Subchronic Toxicity study is most appropriate for the establishment of both Inhalation and dermal long-term systemic Worker DNELs. The NOAEL for this study was 300 mg/kg/day. E.C.H.A. R.I.P. 3.2 Chapter R.8: "Characterization of dose [concentration]-response for human health" guidance was followed in the establishment of the Worker DNELs. Where appropriate Allometric Scaling was applied to estimate the DNEL. There were no "local" adverse effects identified in laboratory animals upon which "Local" DNELs could be based.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 8.8 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 30
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 264 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Section 8.4.2. Figure R.8-3, page 27.
- Justification:
- Not apllicable, starting point is a NOAEL.
- AF for differences in duration of exposure:
- 2
- Justification:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Table R. 8-5, page 35.
- Justification:
- SEE, Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Section 8.4.2. Figure R.8-3, page 27.
- AF for intraspecies differences:
- 5
- Justification:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Appendix R.8-3, Table R.8-19, page77.
- AF for the quality of the whole database:
- 3
- Justification:
- Due to lack of reproductive study data.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.5 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 120
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 300 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Section R.8.4.3.1. pages 30-32, Tables R.8-3 & R.8-4.
- Justification:
- Not applicable, starting point is a NOAEL.
- AF for differences in duration of exposure:
- 2
- Justification:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Table R.8-5, page 35
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Table R.8-3 for the rat.
- Justification:
- Allometric scalling was employeed.
- AF for intraspecies differences:
- 5
- Justification:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Appendix R.8-3, Table R.8-19, page 77.
- AF for the quality of the whole database:
- 3
- Justification:
- Due to lack of reproductive study data.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.5 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 120
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 300 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Section R.8.4.3.1. pages 30-32, Tables R.8-3 & R.8-4.
- Justification:
- Not applicable, starting point is a NOAEL.
- AF for differences in duration of exposure:
- 2
- Justification:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Table R.8-5, page 35
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Table R.8-3 for the rat.
- Justification:
- Allometric scalling was employeed.
- AF for intraspecies differences:
- 5
- Justification:
- Based on E.C.H.A. “Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterization of dose [concentration]-response for human health, Appendix R.8-3, Table R.8-19, page 77.
- AF for the quality of the whole database:
- 3
- Justification:
- Due to lack of reproductive study data.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - General Population
There were no "local" hazards observed for vinyl neononanoate in laboratory animal studies upon which to base "Local" DNELs.
The rat oral GLP, O.E.C.D. Testing Guideline 408 90-Day Subchronic Toxicity study is most appropriate for the establishment of both Inhalation, oral and dermal long-term systemic General Population DNELs. The NOAEL for this study was 300 mg/kg/day. E.C.H.A. R.I.P. 3.2 Chapter R.8: "Characterization of dose [concentration]-response for human health" guidance was followed in the establishment of the General Population DNELs. Allometric Scaling was applied to estimate the oral and dermal long-term systemic DNELs. General Population short-term DNELs are not required as per E.C.H.A. guidance. Short-Term exposure limits are generally only set to protect the work force (SEE E.C.H.A. Guidance Chapter R.8. Section R.8.1.2.5. page 16.).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.